Does extensive genotyping and nasal potential difference testing clarify the diagnosis of cystic fibrosis among patients with single-organ manifestations of cystic fibrosis?
Authors:
- Chee Y OoiCOChee Y Ooi
- Annie DupuisADAnnie Dupuis
- Lynda EllisLELynda Ellis
- Keith JarviKJKeith Jarvi
- Sheelagh MartinSMSheelagh Martin
- Peter N RayPRPeter N Ray
- Leslie SteeleLSLeslie Steele
- Paul KortanPKPaul Kortan
- Tanja GonskaTGTanja Gonska
- Ruslan DorfmanRuslan Dorfman
- Melinda SolomonMSMelinda Solomon
- Julian ZielenskiJZJulian Zielenski
Abstract
The phenotypic spectrum of cystic fibrosis (CF) has expanded to include patients affected by single-organ diseases. Extensive genotyping and nasal potential difference (NPD) testing have been proposed to assist in the diagnosis of CF when sweat testing is inconclusive. However, the diagnostic yield of extensive genotyping and NPD and the concordance between NPD and the sweat test have not been carefully evaluated. We evaluated the diagnostic outcomes of genotyping (with 122 mutations included as disease causing), sweat testing and NPD in a prospectively ascertained cohort of undiagnosed patients who presented with chronic sino-pulmonary disease (RESP), chronic/recurrent pancreatitis (PANC) or obstructive azoospermia (AZOOSP). 202 patients (68 RESP, 42 PANC and 92 AZOOSP) were evaluated; 17.3%, 22.8% and 59.9% had abnormal, borderline and normal sweat chloride results, respectively. Only 17 (8.4%) patients were diagnosable as having CF by genotyping. Compared to sweat testing, NPD identified more patients as having CF (33.2%) with fewer borderline results (18.8%). The level of agreement according to kappa statistics (and the observed percentage of agreement) between sweat chloride and NPD in RESP, PANC and AZOOSP subjects was 'moderate' (65% observed agreement), 'poor' (33% observed agreement) and 'fair' (28% observed agreement), respectively. The degree of agreement only improved marginally when subjects with borderline sweat chloride results were excluded from the analysis. The diagnosis of CF or its exclusion is not always straightforward and may remain elusive even with comprehensive evaluation, particularly among individuals who present at an older age with single-organ manifestations suggestive of CF.Keywords
This publication has 30 references indexed in Scilit:
- Type of CFTR Mutation Determines Risk of Pancreatitis in Patients With Cystic FibrosisGastroenterology, 2011
- Effects of Gender and Age at Diagnosis on Disease Progression in Long-term Survivors of Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Do common in silico tools predict the clinical consequences of amino‐acid substitutions in the CFTR gene?Clinical Genetics, 2010
- Deletion of CFTR Translation Start Site Reveals Functional Isoforms of the Protein in CF PatientsCellular Physiology and Biochemistry, 2009
- Diagnosis of Cystic Fibrosis by Sweat Testing: Age-Specific Reference IntervalsThe Journal of Pediatrics, 2008
- Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus ReportThe Journal of Pediatrics, 2008
- Mutations in the Cystic Fibrosis Transmembrane Regulator Gene and In Vivo Transepithelial PotentialsAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Cystic fibrosis: terminology and diagnostic algorithmsThorax, 2006
- The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitisHuman Genetics, 2005
- Identification of the Cystic Fibrosis Gene: Chromosome Walking and JumpingScience, 1989